Acyclovir - 51079-449-20 - (acyclovir)

Alphabetical Index


Drug Information of Acyclovir

Product NDC: 51079-449
Proprietary Name: Acyclovir
Non Proprietary Name: acyclovir
Active Ingredient(s): 800    mg/1 & nbsp;   acyclovir
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Acyclovir

Product NDC: 51079-449
Labeler Name: UDL Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA075211
Marketing Category: ANDA
Start Marketing Date: 20100723

Package Information of Acyclovir

Package NDC: 51079-449-20
Package Description: 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-449-20) > 1 TABLET in 1 BLISTER PACK (51079-449-01)

NDC Information of Acyclovir

NDC Code 51079-449-20
Proprietary Name Acyclovir
Package Description 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-449-20) > 1 TABLET in 1 BLISTER PACK (51079-449-01)
Product NDC 51079-449
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name acyclovir
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20100723
Marketing Category Name ANDA
Labeler Name UDL Laboratories, Inc.
Substance Name ACYCLOVIR
Strength Number 800
Strength Unit mg/1
Pharmaceutical Classes DNA Polymerase Inhibitors [MoA],Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient]

Complete Information of Acyclovir


General Information